Rhythm Pharmaceuticals, Inc. (RYTM)

Rhythm Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 18, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,859	3,440	2,717	1,641	502	1,314
Market Cap Growth	28.52%	26.64%	65.56%	227.08%	-61.83%	30.31%
Enterprise Value	5,658	3,397	2,419	1,295	176	1,116
Last Close Price	89.20	55.98	45.97	29.12	9.98	29.73
PS Ratio	40.23	26.44	35.09	69.42	159.06	-
PB Ratio	298.93	20.91	16.00	6.21	1.77	7.89
P/TBV Ratio	451.12	221.17	16.69	6.40	1.80	7.89
EV/Sales Ratio	41.34	26.10	31.24	54.79	55.81	-
Debt / Equity Ratio	0.70	0.69	0.63	0.29	0.01	0.02
Asset Turnover	0.42	0.36	0.22	0.07	0.01	-
Inventory Turnover	1.02	0.98	1.61	1.41	-	-
Quick Ratio	2.97	2.94	5.27	8.53	6.81	9.60
Current Ratio	3.30	3.24	5.58	8.90	7.10	10.10
Return on Equity (ROE)	-150.20%	-155.91%	-85.10%	-66.05%	-30.89%	-59.88%
Return on Assets (ROA)	-51.33%	-45.77%	-32.22%	-31.45%	-41.15%	-34.45%
Return on Capital (ROIC)	-74.16%	-59.75%	-37.22%	-35.62%	-46.59%	-37.59%
Earnings Yield	-2.97%	-7.58%	-6.80%	-11.04%	-13.88%	-10.20%
FCF Yield	-1.94%	-3.31%	-5.01%	-10.59%	-29.19%	-9.30%
Buyback Yield / Dilution	-5.45%	-5.76%	-10.65%	-5.08%	-12.40%	-21.15%

Updated May 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q